Skip to main content

Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials
	Lee, Beverly beverly.lee@nih.gov	5E532	Program Officer \| Community Oncology and Prevention Trials
	Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152	5E516	Nurse Consultant \| Community Oncology and Prevention Trials
	Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081	5E434	Program Specialist \| Community Oncology and Prevention Trials
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533	5E448	Program Officer \| Community Oncology and Prevention Trials
	Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials
	Whitman, Cynthia, B.S. [C] cynthia.whitman@nih.gov		Contractor \| Community Oncology and Prevention Trials

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05	Nicholas Hodges, Ph.D.
Nelson, Randy J.	West Virginia University United States	Mechanism Underlying Sleep Disruption by Mammary Tumors	5R21CA276027-02	Marjorie Perloff, M.D.
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1	Elyse LeeVan, M.D., M.P.H.
Nguyen, Sang Minh	Vanderbilt University Medical Center United States	Gut Microbiome Profiles in Association with Breast Cancer Recurrence and Mortality	1R03CA292953-01	Gabriela Riscuta, M.D., CNS
Nicolson, Fay	Dana-Farber Cancer Inst United States	SESORRS endoscopy for the staging and evaluation of colorectal cancer	5R00CA266921-04
NINA, BHARDWAJ,	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI United States	Immune determinants modulating cancer development in Lynch Syndrome	1UG3CA290517-01
Noble, Mark D	University Of Rochester United States	Prevention and treatment of paclitaxel-induced peripheral neuropathy	5R21CA277447-02	Rachel Altshuler, Ph.D.
Nolan, Michael Warren	North Carolina State University Raleigh United States	Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer	5R37CA248797-05	Asad Umar, D.V.M., Ph.D.
Nyamathi, Adeline M	University Of California-Irvine United States	Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India	3R01CA285063-03S2	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-04	Guillermo Marquez, Ph.D.
Ochoa, Augusto C.	Lsu Health Sciences Center United States	Gulf South Clinical Trials Network (Gulf South NCORP)	3UG1CA189854-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Olopade, Olufunmilayo F.	University Of Chicago United States	The Funding Mechanism of the Pilot Trial	5R01CA276652-03	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.	University Of Minnesota United States	Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	5R01CA254270-04	Malgorzata Wojtowicz, M.D.
Onitilo, Adedayo A	Marshfield Clinic Research Foundation United States	Wisconsin NCI Community Oncology Research Program (WiNCORP)	3UG1CA189956-11S1	Vanessa A. White, M.P.H.
Osarogiagbon, Raymond U	Baptist Memorial Hospital - Tipton United States	Baptist Memorial Health Care/Mid South NCORP Consortium	3UG1CA189873-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.